
New
HealthMore in Health→
Study Finds Widening Gaps in Access to GLP-1 Weight-Loss Drugs
Key Takeaways
- Prescription fills among eligible patients rose from 1.9% in 2021 to 16.6% in 2025.
- The study found lower prescription rates across several demographic and socioeconomic groups.
- Disparities were especially pronounced in 2024 and 2025.
DE
DT Editorial Team··via medicalxpress.com